APhA Immunization Training Exam Questions
With Correct Answers
When |looking |at |the |schedule |for |vaccines |that |might |be |indicated |for |children |and |
adolescents |aged |18 |years |or |younger |based |on |medical |indications, |what |does |the |orange |bar
|represent?
a. |Contraindicated.
b. |Precautions |for |vaccination.
c. |Recommended |if |an |additional |risk |factor |is |present.
d. |Additional |doses |may |be |needed |based |on |condition. |- |CORRECT |ANSWER✔✔-b
During |which |step |of |the |Pharmacists' |Patient |Care |Process |would |a |pharmacist |analyze |a |
patient's |need |for |certain |vaccines?
a. |Collect
b. |Assess
c. |Plan
d. |Implement |- |CORRECT |ANSWER✔✔-b
According |to |ACIP |recommendations, |which |of |the |following |needle |lengths |would |be |
appropriate |for |administering |HZV |to |an |adult |patient?
a. |½ |inch.
b. |⅝ |inch.
c. |1 |inch.
,d. |1½ |inch. |- |CORRECT |ANSWER✔✔-b
Which |of |the |following |is |most |likely |to |result |in |an |influenza |pandemic?
a. |Antigenic |drift |in |an |influenza |A |virus.
b. |Antigenic |shift |in |an |influenza |A |virus.
c. |Antigenic |drift |in |an |influenza |B |virus
d. |Antigenic |shift |in |an |influenza |C |virus. |- |CORRECT |ANSWER✔✔-b
Why |was |the |live |attenuated |influenza |vaccine |(LAIV) |removed |from |the |ACIP's |influenza |
vaccine |recommendations?
a. |It |was |shown |to |cause |influenza |in |children |and |adolescents.
b. |Low |effectiveness |of |this |vaccine |was |seen |during |the |2013-2014 |and |2015-2016 |influenza |
seasons.
c. |Serious |adverse |events |were |reported |with |LAIV.
d. |There |was |concern |about |vaccine |supply |issues. |- |CORRECT |ANSWER✔✔-b
Which |of |the |following |best |describes |an |opportunity |for |pharmacists |to |use |diagnosis-based |
screening |to |identify |people |at |risk |for |vaccine-preventable |diseases?
a. |Performing |a |medication |review |for |a |patient |who |has |diabetes.
b. |Recommending |vaccinations |for |a |patient |undergoing |a |splenectomy.
c. |Providing |hospital |discharge |counseling |to |a |patient.
d. |Providing |vaccine |information |at |a |booth |of |a |health |fair. |- |CORRECT |ANSWER✔✔-a
What |is |the |standard |dose |of |epinephrine |for |managing |anaphylaxis?
,a. |0.01 |mg |per |kg |body |weight, |up |to |a |maximum |of |0.5 |mg.
b. |0.1 |mg |per |kg |body |weight, |up |to |a |maximum |of |5 |mg.
c. |0.5 |mg |for |all |patients.
d. |5 |mg |for |all |patients. |- |CORRECT |ANSWER✔✔-a
Which |of |the |following |tetanus |booster |vaccines |would |be |most |appropriate |for |administration
|to |a |12-year-old |boy |who |has |completed |a |primary |series |with |DTaP |and |has |no |known |
allergies?
a. |DTaP.
b. |DT.
c. |Td.
d. |Tdap. |- |CORRECT |ANSWER✔✔-d
HPV |vaccine |is |recommended |for |which |of |the |following |individuals?
a. |36-year-old |woman
b. |27-year-old |woman.
c. |12-year-old |boy.
d. |8-year-old |girl |- |CORRECT |ANSWER✔✔-c
Alex |is |a |32-year-old |man |who |is |scheduled |to |travel |to |a |country |where |hepatitis |A |is |
endemic. |He |leaves |in |3 |weeks |and |will |be |gone |a |month. |He |received |his |first |dose |of |
hepatitis |A |vaccine |today. |Alex |should |be |counseled |to |return |for |his |second |dose |of |hepatitis |
A |vaccine:
a. |In |4 |weeks.
, b. |In |6 |months.
c. |In |2 |years.
d. |Immediately |after |travel. |- |CORRECT |ANSWER✔✔-b
Which |of |the |following |statements |is |true |regarding |varicella-containing |vaccines?
a. |The |potency |of |HZV |is |greater |than |that |of |varicella |vaccine.
b. |The |potency |of |varicella |vaccine |is |greater |than |that |of |HZV.
c. |The |potency |of |varicella |vaccine |is |the |same |as |HZV.
d. |The |vaccines |are |interchangeable. |- |CORRECT |ANSWER✔✔-a
Which |of |the |following |best |describes |how |to |administer |MMR |vaccine |to |an |adult |patient |
weighing |210 |lb?
a. |Inject |subcutaneously |at |a |45° |angle |in |the |outer |aspect |of |the |upper |arm.
b. |Inject |intramuscularly |at |a |45° |angle |in |the |deltoid |muscle.
c. |Inject |subcutaneously |at |a |90° |angle |in |the |outer |aspect |of |the |upper |arm.
d. |Inject |intramuscularly |at |a |90° |angle |in |the |deltoid |muscle. |- |CORRECT |ANSWER✔✔-a
HealthMap |Vaccine |Finder |is |a |free |online |tool |that |allows |pharmacists |to:
a. |Order |vaccines |from |multiple |distributors |through |a |centralized |hub.
b. |Manage |vaccine |inventory |during |shortages.
c. |List |their |vaccination |services |so |patients |can |find |them |when |searching |the |website |for |
nearby |immunizers
d. |Order |free |print |marketing |materials. |- |CORRECT |ANSWER✔✔-c
With Correct Answers
When |looking |at |the |schedule |for |vaccines |that |might |be |indicated |for |children |and |
adolescents |aged |18 |years |or |younger |based |on |medical |indications, |what |does |the |orange |bar
|represent?
a. |Contraindicated.
b. |Precautions |for |vaccination.
c. |Recommended |if |an |additional |risk |factor |is |present.
d. |Additional |doses |may |be |needed |based |on |condition. |- |CORRECT |ANSWER✔✔-b
During |which |step |of |the |Pharmacists' |Patient |Care |Process |would |a |pharmacist |analyze |a |
patient's |need |for |certain |vaccines?
a. |Collect
b. |Assess
c. |Plan
d. |Implement |- |CORRECT |ANSWER✔✔-b
According |to |ACIP |recommendations, |which |of |the |following |needle |lengths |would |be |
appropriate |for |administering |HZV |to |an |adult |patient?
a. |½ |inch.
b. |⅝ |inch.
c. |1 |inch.
,d. |1½ |inch. |- |CORRECT |ANSWER✔✔-b
Which |of |the |following |is |most |likely |to |result |in |an |influenza |pandemic?
a. |Antigenic |drift |in |an |influenza |A |virus.
b. |Antigenic |shift |in |an |influenza |A |virus.
c. |Antigenic |drift |in |an |influenza |B |virus
d. |Antigenic |shift |in |an |influenza |C |virus. |- |CORRECT |ANSWER✔✔-b
Why |was |the |live |attenuated |influenza |vaccine |(LAIV) |removed |from |the |ACIP's |influenza |
vaccine |recommendations?
a. |It |was |shown |to |cause |influenza |in |children |and |adolescents.
b. |Low |effectiveness |of |this |vaccine |was |seen |during |the |2013-2014 |and |2015-2016 |influenza |
seasons.
c. |Serious |adverse |events |were |reported |with |LAIV.
d. |There |was |concern |about |vaccine |supply |issues. |- |CORRECT |ANSWER✔✔-b
Which |of |the |following |best |describes |an |opportunity |for |pharmacists |to |use |diagnosis-based |
screening |to |identify |people |at |risk |for |vaccine-preventable |diseases?
a. |Performing |a |medication |review |for |a |patient |who |has |diabetes.
b. |Recommending |vaccinations |for |a |patient |undergoing |a |splenectomy.
c. |Providing |hospital |discharge |counseling |to |a |patient.
d. |Providing |vaccine |information |at |a |booth |of |a |health |fair. |- |CORRECT |ANSWER✔✔-a
What |is |the |standard |dose |of |epinephrine |for |managing |anaphylaxis?
,a. |0.01 |mg |per |kg |body |weight, |up |to |a |maximum |of |0.5 |mg.
b. |0.1 |mg |per |kg |body |weight, |up |to |a |maximum |of |5 |mg.
c. |0.5 |mg |for |all |patients.
d. |5 |mg |for |all |patients. |- |CORRECT |ANSWER✔✔-a
Which |of |the |following |tetanus |booster |vaccines |would |be |most |appropriate |for |administration
|to |a |12-year-old |boy |who |has |completed |a |primary |series |with |DTaP |and |has |no |known |
allergies?
a. |DTaP.
b. |DT.
c. |Td.
d. |Tdap. |- |CORRECT |ANSWER✔✔-d
HPV |vaccine |is |recommended |for |which |of |the |following |individuals?
a. |36-year-old |woman
b. |27-year-old |woman.
c. |12-year-old |boy.
d. |8-year-old |girl |- |CORRECT |ANSWER✔✔-c
Alex |is |a |32-year-old |man |who |is |scheduled |to |travel |to |a |country |where |hepatitis |A |is |
endemic. |He |leaves |in |3 |weeks |and |will |be |gone |a |month. |He |received |his |first |dose |of |
hepatitis |A |vaccine |today. |Alex |should |be |counseled |to |return |for |his |second |dose |of |hepatitis |
A |vaccine:
a. |In |4 |weeks.
, b. |In |6 |months.
c. |In |2 |years.
d. |Immediately |after |travel. |- |CORRECT |ANSWER✔✔-b
Which |of |the |following |statements |is |true |regarding |varicella-containing |vaccines?
a. |The |potency |of |HZV |is |greater |than |that |of |varicella |vaccine.
b. |The |potency |of |varicella |vaccine |is |greater |than |that |of |HZV.
c. |The |potency |of |varicella |vaccine |is |the |same |as |HZV.
d. |The |vaccines |are |interchangeable. |- |CORRECT |ANSWER✔✔-a
Which |of |the |following |best |describes |how |to |administer |MMR |vaccine |to |an |adult |patient |
weighing |210 |lb?
a. |Inject |subcutaneously |at |a |45° |angle |in |the |outer |aspect |of |the |upper |arm.
b. |Inject |intramuscularly |at |a |45° |angle |in |the |deltoid |muscle.
c. |Inject |subcutaneously |at |a |90° |angle |in |the |outer |aspect |of |the |upper |arm.
d. |Inject |intramuscularly |at |a |90° |angle |in |the |deltoid |muscle. |- |CORRECT |ANSWER✔✔-a
HealthMap |Vaccine |Finder |is |a |free |online |tool |that |allows |pharmacists |to:
a. |Order |vaccines |from |multiple |distributors |through |a |centralized |hub.
b. |Manage |vaccine |inventory |during |shortages.
c. |List |their |vaccination |services |so |patients |can |find |them |when |searching |the |website |for |
nearby |immunizers
d. |Order |free |print |marketing |materials. |- |CORRECT |ANSWER✔✔-c
